Matasa da yawa da ke fama da matsalar rashin karfin mazakuta suna zaton cewa karancin sinadarin testosterone ne ke da alhakin hakan. Wannan ba abu ne mai yiwuwa ba domin karancin sinadarin testosterone ne ake bukata don cimma karfin mazakuta, bincike da dama na ED sun nuna babu wata alaka da sinadarin testosterone, kuma karin sinadarin T yana aiki ne kawai ga marasa lafiya masu tsananin rashin karfin mazakuta.
Matakan ƙwayoyin testosterone na Plasma na aiki da jima'i da maza.
Arch Sex Behav. 1980 Oktoba;9(5):355-66.
Schwartz MF , Kolodny RC , Masters WH.
Abstract
An kwatanta matakan testosterone a cikin jini a cikin rukunin maza 341 da ke fama da matsalar jima'i da waɗanda ke cikin maza 199 da ke fama da matsalar jima'i. Duk waɗanda aka yi wa gwajin sun kasance mahalarta a cikin shirin maganin jima'i na mako 2 mai zurfi a Cibiyar Masters & Johnson. An yi gwajin testosterone ta amfani da hanyoyin radioimmunoassay bayan gwajin chromatography na shafi; an sami dukkan samfuran jini a rana ta biyu ta magani tsakanin 8:00 da 9:00 na safe bayan azumin dare. Matakan testosterone masu yawo a cikin maza masu aikin jima'i na yau da kullun (matsakaicin 635 ng/dl) ba su bambanta sosai da ƙimar testosterone a cikin maza masu matsalar jima'i ba (matsakaicin 629 ng/dl). Duk da haka, maza masu matsalar rashin ƙarfi na farko (N = 13) suna da matakan testosterone mafi girma fiye da maza masu matsalar rashin ƙarfi na biyu (N = 180), tare da matsakaicin matakan 710 da 574 ng/dl, bi da bi (p < 0.001). Matsakaicin matakin testosterone ga maza masu ƙarancin iya fitar da maniyyi shine 660 ng/dl (N = 15), yayin da ga maza masu fitar da maniyyi kafin lokaci matsakaicin shine 622 ng/dl (N = 91). Yawan sinadarin testosterone a cikin jini bai shafi sakamakon magani ba amma yana da alaƙa da shekarun marasa lafiya.
Aikin kwayoyin cutar Pituitary yana aiki a marasa lafiya da rashin ciwon daji da tsohuwar haɗari.
Arch Sex Behav. 1979 Janairu;8(1):41-8.
Pirke KM , Kockott G , Aldenhoff J , Besinger U , Feil W.
Abstract
An yi nazarin tsarin ƙwanƙolin pituitary a cikin maza masu rashin ƙarfin maza. An yi nazarin marasa lafiya takwas masu rashin ƙarfin mazakuta na farko masu shekaru 22-36, maza takwas masu ƙarancin ƙarfin mazakuta na biyu masu shekaru 29-55, da maza 16 masu ƙarancin ƙarfin mazakuta da wuri masu shekaru 23-43. An ƙara raba rukuni na ƙarshe zuwa ƙungiyoyi biyu: marasa lafiya E1 (n = 7) marasa lafiya da E2 (n = 9) marasa lafiya waɗanda ke da damuwa da halayen gujewa zuwa ga ayyukan jima'i. An yi aiki a matsayin ƙungiyar kulawa bayan binciken tabin hankali da na jiki. Ba a yi la'akari da marasa lafiya da ke korafin rashin ƙarfin mazakuta a cikin binciken ba. An sami samfuran jini goma a jere a cikin tsawon awanni 3 daga kowane majiyyaci. An auna hormone na Luteinizing (LH), jimlar testosterone, da testosterone kyauta (ba mai furotin ba). Nazarin ƙididdiga ya nuna babu wani bambanci mai mahimmanci tsakanin marasa lafiya da masu sarrafawa na yau da kullun.
Magunguna da ƙwayoyin testosterone da testosterone a cikin maza da rashin ƙarfi, oligospermia, azoospermia, da hypogonadism.
Br Med J. 1974 Mar 2;1 (5904):349-51.
Abstract
Matsakaicin matakan testosterone a cikin jini (+/- SD), ta amfani da Sephadex LH-20 da haɗin furotin mai gasa, sun kasance 629 +/- 160 ng/100 ml ga ƙungiyar maza 27 na yau da kullun, 650 +/- 205 ng/100 ml ga maza 27 marasa ƙarfi waɗanda ke da halayen jinsi na biyu na yau da kullun, 644 +/- 178 ng/100 ml ga maza 20 da ke da oligospermia, da 563 +/- 125 ng/100 ml ga maza 16 na azoospermic. Babu ɗayan waɗannan ƙimar da ya bambanta sosai. Ga maza 21 da ke da shaidar asibiti ta hypogonadism, matsakaicin testosterone a cikin jini (+/- SD), a 177 +/- 122 ng/100 ml, ya bambanta sosai (P < 0.001) daga na maza na yau da kullun. Matsakaicin alaƙar ɗaure testosterone (kamar yadda aka auna ta hanyar yawan plasma da ake buƙata don ɗaure 50% na (3) H-testosterone tracer) sun yi kama da maza na yau da kullun, marasa ƙarfi, da kuma maza masu oligospermic. Kodayake ƙasa da maza masu azoospermic, bambancin bai yi yawa ba (P >0.1). Ga maza 12 daga cikin maza 16 masu hypogonadal, dangantakar ɗaure testosterone ta kasance al'ada, amma an sami alaƙar ɗaure, kamar waɗanda ake samu a cikin mata manya na yau da kullun ko samari waɗanda ba su kai shekara ba (kimanin matakan maza manya biyu), an gano su a cikin lokuta huɗu na jinkirin balaga. Waɗannan binciken suna taimakawa wajen bayyana dalilin da yasa maganin androgen yawanci ba shi da amfani wajen magance rashin ƙarfi.
Shin testosterone yana da rawar gani a aikin aiki?
Am J Med. 2006 Mayu;119(5):373-82.
Mikhail N.
KASHI:
Duk da rawar da testosterone ke takawa wajen inganta sha'awar jima'i, ainihin gudummawarsa ga tsayuwar maza har yanzu ba a fayyace ba . Manyan manufofin wannan bita sune bayyana rawar da testosterone ke takawa a cikin aikin tsayuwar maza da kuma kimanta darajar maganinsa ga maza masu matsalar tsayuwar maza (ED).
MUTANE:
An gudanar da bitar adabin da suka dace (Turanci, Faransanci, da Sifaniyanci) daga 1939 zuwa Yuni 2005 ta amfani da hanyoyin bayanai daga MEDLINE, littattafan rubutu na endocrinology, da kuma binciken hannu na nassoshi daga asali da sake dubawa. An haɗa da gwaje-gwajen asibiti, nazarin dabbobi, rahotannin shari'o'i, bita, da jagororin manyan alaƙa.
Sakamakon:
Nazarin dabbobi da na ɗan adam na farko sun nuna cewa testosterone na iya sauƙaƙa tashin jiki ta hanyar yin aiki a matsayin mai rage yawan jijiyoyin azzakari da kuma sinusoids na cavernous. Bayan yin castration, yawancin maza, amma ba duka ba, sun sami raguwar tashin jiki gaba ɗaya ko gaba ɗaya. Hypogonadism ba abu ne da aka saba gani a cikin ED ba, yana faruwa a kusan kashi 5% na lokuta, kuma gabaɗaya, akwai rashin alaƙa tsakanin matakan testosterone na jini, lokacin da suke a cikin matakan al'ada ko matsakaici, da aikin jima'i.
Yawancin gwaje-gwajen da ake amfani da testosterone don magance ED a cikin maza masu hypogonadal suna fama da matsalolin hanyoyin aiki kuma suna ba da rahoton sakamako marasa daidaituwa, amma gabaɗaya, suna nuna cewa testosterone na iya zama mafi kyau fiye da placebo. Aikin mikewa yana da yuwuwar ingantawa tare da maganin testosterone a cikin marasa lafiya da ke da matsanancin matakan hypogonadism.
Sanarwar Testosterone na iya bunkasa amsawa ga magungunan 5 (PDE5) wadanda ke cikin magunguna da maza da maza da testosterone marasa ƙarfi. Maimaita yawan nauyin sallar sautin duka testosterone shine hanya mai sauƙi da sauƙi don kimanta androgenecity, amma ana bada shawara akan freetostailable testosterone a cikin yanayin da ke canza matakan jinsi-hormone-ɗaure globulin (SHBG), irin su tsofaffi da kuma a cikin kiba.
TAMBAYOYI:
Bayanan da ake da su sun nuna cewa a mafi yawan maza, matakan testosterone da ke yawo a jiki, waɗanda ba su kai na al'ada ba, suna da mahimmanci ga tashin hankali na yau da kullun kuma hakan yana nufin cewa matakan testosterone da ke cikin jini ba za su yi tasiri sosai ga aikin jima'i ba. Ana buƙatar tantance hypogonadism a cikin duk mazan da ke fama da ED don gano lamuran hypogonadism mai tsanani da kuma wasu lokuta na hypogonadism mai sauƙi zuwa matsakaici, waɗanda za su iya amfana daga maganin testosterone.
Muhimmancin hypogonadism a cikin dysfunction erectile.
Duniya J Urol. Disamba 2006;24(6):657-67.
Buvat J 1 , Bou Jaoudé G.
Abstract
Don sake nazarin muhimmancin hypogonadism, wanda aka bayyana a matsayin matakin ƙananan testosterone (T), a cikin dysfunction erectile (ED). Review na wallafe-wallafen.
Serum T yana ƙasa da 3 ng / ml a 12% na marasa lafiya ED, ciki har da 4% kafin da 15% bayan shekaru 50. Sauyawa a cikin mazajen da ke dauke da hypogonadism mai tsanani ya nuna cewa sha'awar jima'i da ƙwaƙwalwa, da kuma yawan lokacin yin jima'i da kuma tsararren lokaci ba su da tabbaci. Ƙwararrakin ƙwayoyin cuta suna dogara da T-dogara. Hanyoyin T a kan aikin jima'i sun dogara ne da mutum ɗaya, amma yana iya canzawa tsakanin mutane, daga 2 zuwa 4.5 ng / ml. Ana buƙatar ƙarin shaida don tabbatar da tasiri mai tasiri na T a kan tsarin ƙwayoyin cuta na jikin mutum kamar yadda yake a cikin dabbobi.
Babu wata alaƙa mai gamsarwa tsakanin T da ED da aka samu a cikin nazarin cututtuka. Dangane da ƙwarewar asibiti, kodayake wani bincike-bincike na gwaje-gwajen da aka gudanar bazuwar ya tabbatar da cewa maganin T yana dawo da aikin jima'i a cikin ƙananan marasa lafiya masu ƙarancin jini tare da T ƙasa da 3.46 ng/ml, tasirin wannan maganin ya kasance abin takaici lokacin da aka yi amfani da shi kaɗai a cikin tsofaffi marasa lafiya da ke ba da shawara ga ED waɗanda daga baya aka gano suna da ƙarancin jini bayan auna T na yau da kullun. Waɗannan mummunan sakamakon za a iya bayyana su ta hanyar yawan kamuwa da cututtukan haɗin gwiwa, da kuma gaskiyar cewa ED da kanta na iya haifar da ƙarancin jini.
Haɗin haɗawa tare da T da PDE5 mai hanawa (PDE5I) na iya zama tasiri a cikin marasa lafiya ED yayin da T kawai farfadowa ya kasa. Duk da haka, ana buƙatar ƙarin shaida don tabbatar da ra'ayin cewa an buƙatar ƙarami na T don cikakkiyar sakamako na PDE5I a wasu mutane, tun da PDE5I ya iya mayar da cikakke kayan aiki a cikin mutane mai tsanani. Kodayake ƙananan matakin T ba koyaushe ne kawai dalili na ED a hypogonadal ED marasa lafiya, akwai wasu mahimmancin amfani a tantancewa ga hypogonadism a ED. Tashin ƙananan matakin T ya ƙaddara gwajin 3 watanni na T, kafin hada PDE5I idan T kawai farfadowa ya kasa.